Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9932 USD | +1.97% | +8.36% | -29.06% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 73K | Sales 2025 * | 4.5M | Capitalization | 151M |
---|---|---|---|---|---|
Net income 2024 * | -164M | Net income 2025 * | -153M | EV / Sales 2024 * | 3,802 x |
Net Debt 2024 * | 126M | Net Debt 2025 * | 193M | EV / Sales 2025 * | 76.6 x |
P/E ratio 2024 * |
-0.97
x | P/E ratio 2025 * |
-1.4
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.3% |
Latest transcript on Seres Therapeutics, Inc.
1 day | +1.97% | ||
1 week | +8.36% | ||
Current month | -0.68% | ||
1 month | +0.26% | ||
3 months | -12.88% | ||
6 months | -4.50% | ||
Current year | -29.06% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 14-10-31 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-10-21 |
Chief Tech/Sci/R&D Officer | - | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 15-03-31 |
Director/Board Member | 68 | 23-01-03 | |
Richard Kender
BRD | Director/Board Member | 68 | 14-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +8.48% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1 | +2.67% | 2,092,073 |
24-05-30 | 0.974 | +5.67% | 3,472,855 |
24-05-29 | 0.9217 | -0.84% | 1,004,753 |
24-05-28 | 0.9295 | +1.41% | 2,189,656 |
24-05-24 | 0.9166 | +0.96% | 1,483,877 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.06% | 150M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MCRB Stock